Articles On Impression Healthcare (ASX:IHL)

On 9 August 2019, the Australian Benchmark index S&P/ASX 200 closed at 6,584.4, up by 16.30 points or 0.25% from the previous close. The broader All Ordinaries Index edged up by 0.3%, settling at 6,663.4. Investors are carefully eyeing...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Impression Healthcare (ASX: IHL) has moved to extend its medicinal cannabis market coverage after unveiling the all-new cannabinoid drug discovery brand Incannex Pharmaceuticals. As a new entity, Incannex will engage Linnea SA, an EU-based,...

On Stockhead today – the final wrap from Diggers and Dealers, the feds are finally on board with legal pot, and investors want ASIC to find some backbone. But first here’s what you need to know.   The day ahead If there’s one thing we can b...

The federal government has taken steps to cut red tape and speed up the granting of licences for Australia’s cannabis players. Health Minister Greg Hunt said the federal government would boost the nation’s medicinal cannabis industry by pri...

On Stockhead today – mining lithium from seawater, our monthly dairy stocks update, and why Hot Copper’s not leading the stocks chat space anymore. But first here’s what you need to know. The day ahead It’s the final day of Diggers and Deal...

Medicinal cannabis company Cannvalate is getting its ducks in a row ahead of its planned IPO, strengthening its board with the appointment of Dr Amit Vohra as chief operating officer. Dr Vohra was formerly the head of strategy and health so...

Barely a week after Aurora announced a deal with the Ultimate Fighting Championship (UFC), Australia’s very own Impression Healthcare (ASX: IHL) has made a move that emulates one of Canada’s most prominent cannabis developers. Earlier this...

Data analytics company Nielsen predicts that the American cannabis market will hit $US41 billion ($59.5 billion) by 2025 — a fivefold increase over 2018. While a good chunk of cannabis products are still illegal in the US, Nielsen reckons s...

Since the ASX is flooded with quarterlies, we’ve summarised a list of the five health companies that got the biggest share-price boost in morning trade due to 4C releases: Oncosil Medical (ASX: OSL) As Oncosil is at the research and develop...

One of the world’s largest cannabis companies and the world’s premier mixed martial arts organisation have struck a deal to conduct a joint clinical research program into hemp-derived cannabidiol (CBD) – with intentions of creating a high-p...

Impression Healthcare (ASX: IHL) has tweaked its internal structure by appointing Dr Sud Agarwal, a leading figure in the medicinal cannabis industry as its Chief Medical Officer and non-executive director. The newly appointed executive is...

Taking the cannabis market to the next level, the US is now taking a closer look at the industry’s lack of access to financial services. Forbes reported on Tuesday that a Republican-controlled Senate committee had scheduled a hearing for ne...

Impression Healthcare (ASX: IHL) has extended the global coverage of its Fitguard by Gameday concussion monitoring system by extending its exclusive licensing agreement with Force Impact Technologies. The deal encompasses a great deal more...

The relative strength index (RSI) is an important technical indicator for stock traders. It provides a measure of which stocks are most in demand, and which stocks investors are neglecting. Often, changes in the RSI are reflective of market...

Californian cannabis company Caliva has signed on billionaire rapper Shawn “Jay-Z” Carter to promote its brand as the drug becomes legal recreationally in more states. Caliva said Jay-Z, as the company’s chief brand strategist, would “play...

Wth the legalisation of medical cannabis in many countries like Canada, the global medical cannabis industry has boomed quite a bit in recent times. Let’s take a quick look at 20 cannabis companies trading on ASX. Cann Group Limited (ASX:...

Australia is home to some of the top physicians as well as healthcare professionals. For more than 30 years, various companies across the globe have depended on the clinical trial in Australia and its capability to deliver timely results wi...

Impression Healthcare (ASX: IHL) is on the brink of conducting a sleep apnoea trial with its own variant of the cannabinoid medicine Dronabinol after establishing a supply agreement for the drug and submitting the necessary paperwork with A...

Impression Healthcare (ASX: IHL) has unveiled a brand-new exclusive research and supply agreement that will see the healthcare company become the official traumatic brain injury research partner and mouthguard supply partner for Boxing Aust...

This week the US state of Illinois became the first to pass a bill allowing retail sales of recreational marijuana. From the start of 2020, anyone over the age of 21 will be allowed to possess up to 30 grams of cannabis, and adult visitors...

Impression Healthcare’s (ASX: IHL) “world first” clinical trial using its cannabidiol (CBD)-based mouthwash and toothpaste to treat gingivitis and periodontitis (gum disease) has now been registered with Australian and New Zealand Clinical...